MedTrace Logo

Granisteron Versus Metoclopramide in Laparoscopic Cholecystectomy

NCT04899817 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2021-05-25

No results posted yet for this study

Summary

Study aims at comparing the effect of granisteron with that of metoclopramide in patients undergoing lab cholecystectomy

Conditions

  • Nausea and Vomiting, Postoperative

Interventions

DRUG

Granisetron

The drug is given after induction of general anesthesia

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Eman M Esmail · Assiut University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-05-31
Primary Completion
2022-03-31
Completion
2022-04-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04899817 on ClinicalTrials.gov